What are the signs that HER2-Positive Breast Cancer has recurred

Signs That HER2-Positive Breast Cancer Has Recurred

Breast cancer recurrence means the cancer has returned after initial treatment. For HER2-positive breast cancer specifically, it's important to know what signs to watch for and what tests your care team will use to detect recurrence.

Types of Recurrence

According to the NCCN Guidelines for Invasive Breast Cancer, breast cancer can return in several ways:

Local recurrence - Cancer returns to the breast or chest wall where the original cancer was treated

Regional recurrence - Cancer returns to lymph nodes under the arm (axillary nodes) or lymph nodes near the breastbone

Metastatic recurrence - Cancer spreads to distant parts of the body (bones, lungs, liver, brain). This is the most serious type and is called metastatic breast cancer.

Physical Signs You Might Notice

While some recurrences have no symptoms, watch for:

• New lumps or thickening in the breast, chest wall, or underarm area
• Skin changes - dimpling, redness, swelling, or skin that looks like orange peel
• Nipple changes - discharge, inversion, or scaling
• Persistent pain in the chest, bones, or other areas
• Swelling in the arm or hand
• Persistent cough or shortness of breath (if lung involvement)
• Headaches or neurological symptoms (if brain involvement)
• Abdominal swelling or pain (if liver involvement)

Medical Tests Your Doctor Will Order

According to NCCN Guidelines, when recurrence is suspected, your care team will perform restaging - repeating many of the tests from your original diagnosis:

Blood tests:

• CBC (complete blood count)
• Comprehensive metabolic panel (including liver function tests)
• Alkaline phosphatase (enzyme that can be elevated with bone involvement)

Imaging studies:

• Chest CT (with or without contrast)
• Abdominal/pelvis CT or MRI with contrast
• Brain MRI with contrast (if you have neurological symptoms)
• Spine MRI with contrast (if you have back pain or cord compression symptoms)
• Bone scan or PET/CT scan (to detect bone metastases)

Biomarker testing: This is particularly important for HER2-positive breast cancer. Your doctor will:

• Perform a biopsy of the recurrent tumor to retest for HER2 status
• Recheck ER/PR status (estrogen and progesterone receptors)
• Test for genetic mutations that might guide treatment

Why retesting matters: According to NCCN Guidelines, HER2 status and hormone receptor status can change between the primary tumor and recurrent disease. This is critical because it directly affects which treatments will work best for you.

Why This Matters for HER2-Positive Breast Cancer

HER2-positive cancers tend to be more aggressive, which means:

• Regular follow-up is especially important
• Your care team will be vigilant about detecting recurrence early
• If recurrence is found, HER2-targeted therapies (like trastuzumab/Herceptin or pertuzumab) remain important treatment options

What to Do If You Notice Symptoms

Don't wait. Contact your oncologist immediately if you notice any of these signs. Early detection of recurrence often leads to better treatment outcomes.

Questions to ask your care team:

1. How often should I have follow-up appointments and imaging?
2. What specific symptoms should I report immediately?
3. If recurrence is found, will my HER2 status be retested?
4. How will my previous treatments affect my recurrence treatment options?
5. What is my personalized surveillance plan based on my specific cancer characteristics?

---

This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions.